Workflow
WESTERN ANIMAL(300106)
icon
Search documents
西部牧业:8月自产生鲜乳生产量2540.33吨,同比减少7.27%
Bei Jing Shang Bao· 2025-09-03 13:38
北京商报讯(记者 孔文燮)9月3日,西部牧业晚间公告,8月公司自产生鲜乳生产量为2540.33吨,环比 增长4.8%,同比减少7.27%。 ...
9月3日晚间重要公告一览
Xi Niu Cai Jing· 2025-09-03 10:18
Group 1 - Shengtun Mining plans to repurchase shares worth between 500 million and 600 million yuan, with a maximum repurchase price of 11.82 yuan per share, aimed at employee stock ownership plans or equity incentives [1] - Kangnbei received a drug registration certificate for Linggui Shugan Granules, which is derived from traditional Chinese medicine and is used for treating phlegm and dampness due to Yang deficiency [2] - Zhangjiang Hi-Tech intends to publicly transfer 100% equity and related debts of Shanghai Jixin Rui Construction Technology Co., Ltd. with a total price not less than 151 million yuan [3] Group 2 - Shankai Intelligent won a bid for a metering device procurement project worth 13.318 million yuan from Hohhot Water Supply Company [4] - Hason Co. plans to jointly establish a supply chain company with a registered capital of 10 million yuan, in which Hason will hold a 10% stake [5] - Pudong Construction's subsidiaries won multiple major projects with a total amount of 1.271 billion yuan [6] Group 3 - Jinling Pharmaceutical received approval for the Phase III clinical trial of Olaratogrel tablets, which are used for treating moderate to severe pain associated with endometriosis [8] - Menohua's subsidiary obtained a drug registration certificate for Mosapride Citrate Tablets, aimed at improving gastrointestinal symptoms [10] - Shapuaisi's major shareholder plans to reduce holdings by up to 2% of the company's shares due to personal financial needs [11] Group 4 - Changyuan Power reported an August electricity generation of 3.771 billion kWh, a year-on-year decrease of 6.03% [15][16] - Xibu Livestock's August fresh milk production increased by 4.8% month-on-month but decreased by 7.27% year-on-year [19] - Yong'an Pharmaceutical's actual controller and chairman had their detention lifted, allowing them to resume normal duties [20] Group 5 - Jinkai Intelligent's director resigned due to work adjustments [22] - Xinhua Medical received a Class II medical device registration for an endoscope cleaning workstation [23] - Haishi Science and Technology's innovative drug HSK47388 received approval for a new indication clinical trial [25] Group 6 - Baotai Co. plans to participate in a land use rights auction in Baoji City with a starting price of 57.34 million yuan [26] - Minfeng Special Paper received a government subsidy totaling 11.2 million yuan [27] - Jiuchang Bio obtained a medical device registration for a heparin-binding protein assay kit [29] Group 7 - Jingao Technology plans to repurchase shares worth between 200 million and 400 million yuan, with a maximum price of 17.36 yuan per share [31] - Youxunda won a bid for a metering equipment project from China Southern Power Grid worth approximately 161 million yuan [32] - Qianli Technology reported an August vehicle sales increase of 168.55% year-on-year [32] Group 8 - Guangzhou Port expects an August container throughput increase of 1.2% year-on-year [32] - Kexing Pharmaceutical's GB08 injection completed the first subject enrollment for Phase II clinical trials [33] - Wu Ming Pharmaceutical plans to transfer 98.9% of its subsidiary's shares to a newly established wholly-owned subsidiary [34] Group 9 - Shanghai Electric's acquisition of K-Electric Limited shares has not yet completed the transfer [35] - Fulai New Materials plans to raise no more than 710 million yuan through a private placement [36] - Huaren Health's drug registration application for a new type of potassium ion competitive acid blocker has been accepted [37]
西部牧业:8月自产生鲜乳生产量环比增长4.8%
Group 1 - The core point of the article is that Western Pastoral (300106) announced its fresh milk production figures for August, indicating a month-on-month increase but a year-on-year decrease [1] Group 2 - In August, the company's self-produced fresh milk production reached 2,540.33 tons, representing a month-on-month growth of 4.8% [1] - However, the production volume showed a year-on-year decrease of 7.27% [1]
西部牧业8月自产生鲜乳生产量同比下降7.27%
Zhi Tong Cai Jing· 2025-09-03 08:23
西部牧业(300106)(300106.SZ)披露自产生鲜乳销售情况,公司2025年8月自产生鲜乳生产量2540.33 吨,同比下降7.27%。 ...
西部牧业(300106.SZ)8月自产生鲜乳生产量同比下降7.27%
智通财经网· 2025-09-03 08:21
智通财经APP讯,西部牧业(300106.SZ)披露自产生鲜乳销售情况,公司2025年8月自产生鲜乳生产量 2540.33吨,同比下降7.27%。 ...
西部牧业(300106) - 关于公司自产生鲜乳销售情况的公告
2025-09-03 08:12
特此公告。 新疆西部牧业股份有限公司董事会 2025 年 9 月 3 日 1 关于公司自产生鲜乳销售情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 导性陈述或重大遗漏。 新疆西部牧业股份有限公司(以下简称"公司")主要经营业务 为乳制品加工与销售、饲料生产与销售、自产生鲜乳生产与销售、外 购生鲜乳收购与销售、种畜养殖与销售、分割肉加工与销售等。根据 《深圳证券交易所上市公司自律监管指引第 3 号——行业信息披露》 的相关规定,公司现对养殖业务月度生产情况进行公告。 | 项 | 目 | | 2025 | 年 8 | 月 | 本月比上月增 | 本月比上年同 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | 减比率(%) | 期增减比率(%) | | 自产生鲜乳 | | 生产量(吨) | | | 2,540.33 | 4.80% | -7.27% | 证券代码:300106 证券简称:西部牧业 公告编号:临 2025-040 新疆西部牧业股份有限公司 ...
西部牧业股价跌5.16%,嘉实基金旗下1只基金位居十大流通股东,持有265.19万股浮亏损失161.77万元
Xin Lang Cai Jing· 2025-09-03 07:55
Group 1 - The core point of the news is that Western Animal Husbandry's stock price dropped by 5.16% to 11.22 CNY per share, with a trading volume of 1.25 billion CNY and a turnover rate of 5.11%, resulting in a total market capitalization of 2.371 billion CNY [1] - Western Animal Husbandry, established on June 18, 2003, and listed on August 20, 2010, is primarily engaged in dairy product processing and sales, feed production and sales, meat processing and sales, and breeding livestock [1] - The company's main business revenue composition is as follows: dairy products account for 86.28%, feed 8.25%, and other products 5.46% [1] Group 2 - Among the top circulating shareholders of Western Animal Husbandry, a fund under Harvest Fund Management, specifically Harvest Agricultural Industry Stock A (003634), entered the top ten in the second quarter, holding 2.6519 million shares, which is 1.25% of the circulating shares [2] - As of the latest data, Harvest Agricultural Industry Stock A has a total scale of 1.034 billion CNY, with a year-to-date return of 9.97%, ranking 3586 out of 4222 in its category, and a one-year return of 23.65%, ranking 3362 out of 3783 [2] - The fund manager, Wu Yue, has a tenure of 6 years and 156 days, with a total fund asset scale of 3.321 billion CNY, achieving a best fund return of 63.07% during his tenure [2]
西部牧业(300106.SZ):2025年中报净利润为-4360.03万元,同比亏损放大
Xin Lang Cai Jing· 2025-08-28 02:31
2025年8月28日,西部牧业(300106.SZ)发布2025年中报。 公司最新毛利率为8.42%,在已披露的同业公司中排名第22,较上季度毛利率增加0.74个百分点,实现2个季度连续上涨,较去年同期毛利率减少2.78个百分 点。最新ROE为-11.51%,在已披露的同业公司中排名第22,较去年同期ROE减少4.71个百分点。 公司摊薄每股收益为-0.21元,在已披露的同业公司中排名第21,较去年同报告期摊薄每股收益减少0.04元。 公司最新总资产周转率为0.36次,在已披露的同业公司中排名第7,较去年同期总资产周转率减少0.02次,同比较去年同期下降5.89%。最新存货周转率为 4.26次,在已披露的同业公司中排名第6,较去年同期存货周转率增加0.60次,实现2年连续上涨,同比较去年同期上涨16.44%。 公司股东户数为2.60万户,前十大股东持股数量为9721.74万股,占总股本比例为46.00%,前十大股东持股情况如下: 公司营业总收入为3.96亿元,在已披露的同业公司中排名第19,较去年同报告期营业总收入减少5631.68万元,同比较去年同期下降12.45%。归母净利润 为-4360.03万元,在已 ...
西部牧业:2025年上半年净利润-4360.03万元,同比下降26.48%
Jing Ji Guan Cha Wang· 2025-08-27 16:02
Group 1 - The core viewpoint of the article highlights that Western Pastoral (300106) reported a decline in both revenue and net profit for the first half of 2025, indicating financial challenges faced by the company [1] - The company achieved an operating income of 396 million yuan, representing a year-on-year decrease of 12.45% [1] - The net profit for the first half of 2025 was -43.6 million yuan, reflecting a year-on-year decline of 26.48% [1] Group 2 - The basic earnings per share (EPS) were reported at -0.2063 yuan [1] - The weighted average return on equity (ROE) was -10.88%, indicating negative returns for shareholders [1]
乳制品需求低迷拖累业绩 西部牧业H1亏损扩大|财报解读
Xin Lang Cai Jing· 2025-08-27 11:19
Core Viewpoint - The performance of Western Dairy is under pressure due to weak dairy product consumption and supply-demand imbalance, leading to a significant increase in net losses in the first half of 2025 compared to the previous year [1][2] Financial Performance - In the first half of 2025, the company's operating revenue was 396 million yuan, a year-on-year decrease of 12.45% [1] - The net loss attributable to the parent company was 43.6 million yuan, widening from a net loss of 34.47 million yuan in the same period last year [1] - The net cash flow from operating activities turned positive at 20.45 million yuan, primarily due to increased cash inflows from sales and subsidies [1] - The net cash flow from financing activities doubled due to an increase in bank loans [1] Market Conditions - Dairy product demand has weakened since September 2021, while production has rebounded, resulting in a continuous decline in raw milk prices for over three years [1] - As of the third week of August, the average price of fresh milk in major producing provinces was 3.02 yuan per kilogram, unchanged from the previous week and down 5.6% year-on-year [1] Strategic Actions - To capture market share, the company has implemented promotional strategies, but these have not yielded significant results [1] - Revenue for 2023-2024 and the first half of 2025 has continued to decline by double digits year-on-year, with a downward trend in sales gross margin over the past five years [1] Cost Management - Research and development expenses decreased by 51% in the first half of 2025 [2] - Sales expenses were reduced by 39%, attributed to the end of cooperation with subsidiaries and a decrease in sales commissions and promotional costs [2] - Management expenses increased by 41%, amounting to 30.73 million yuan in the first half of 2025 [2]